James C. Cradock

902 total citations
40 papers, 729 citations indexed

About

James C. Cradock is a scholar working on Molecular Biology, Pharmacology and Occupational Therapy. According to data from OpenAlex, James C. Cradock has authored 40 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Pharmacology and 5 papers in Occupational Therapy. Recurrent topics in James C. Cradock's work include Cancer therapeutics and mechanisms (6 papers), Safe Handling of Antineoplastic Drugs (5 papers) and Forensic Toxicology and Drug Analysis (5 papers). James C. Cradock is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), Safe Handling of Antineoplastic Drugs (5 papers) and Forensic Toxicology and Drug Analysis (5 papers). James C. Cradock collaborates with scholars based in United States, Malaysia and Ukraine. James C. Cradock's co-authors include Guirag Poochikian, Karl P. Flora, J. Paul Davignon, B. Rao Vishnuvajjala, Charles K. Grieshaber, Daniel F. Hoth, Jacqueline Plowman, Aquilur Rahman, Anthony M. Guarino and Charles L. Litterst and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Clinical Infectious Diseases and Annals of the New York Academy of Sciences.

In The Last Decade

James C. Cradock

39 papers receiving 672 citations

Peers

James C. Cradock
T. S. Anantha Samy United States
Karl P. Flora United States
Henry R. Wolfe United States
I Viano Italy
X Rabasseda United States
Margaret E. Olson United States
R.N. Seelye New Zealand
Alfred Chung United States
T. S. Anantha Samy United States
James C. Cradock
Citations per year, relative to James C. Cradock James C. Cradock (= 1×) peers T. S. Anantha Samy

Countries citing papers authored by James C. Cradock

Since Specialization
Citations

This map shows the geographic impact of James C. Cradock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James C. Cradock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James C. Cradock more than expected).

Fields of papers citing papers by James C. Cradock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James C. Cradock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James C. Cradock. The network helps show where James C. Cradock may publish in the future.

Co-authorship network of co-authors of James C. Cradock

This figure shows the co-authorship network connecting the top 25 collaborators of James C. Cradock. A scholar is included among the top collaborators of James C. Cradock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James C. Cradock. James C. Cradock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Xin, Amy Q. Wang, Lea Latham, et al.. (2017). Safety, pharmacokinetics and sialic acid production after oral administration of N -acetylmannosamine (ManNAc) to subjects with GNE myopathy. Molecular Genetics and Metabolism. 122(1-2). 126–134. 44 indexed citations
2.
Nasr, Mohamed, James C. Cradock, & Margaret I. Johnston. (1992). Computer-Assisted Structure-Activity Correlations of Halodideoxynucleoside Analogs as Potential Anti-HIV Drugs. AIDS Research and Human Retroviruses. 8(2). 135–144. 18 indexed citations
3.
McGowan, John J., Joseph E. Tomaszewski, James C. Cradock, et al.. (1990). Overview of the Preclinical Development of an Antiretroviral Drug, 2′,3′-Dideoxyinosine. Clinical Infectious Diseases. 12(Supplement_5). S513–S521. 40 indexed citations
4.
Sager, Polly R., James C. Cradock, Charles L. Litterst, et al.. (1990). In Vitro Testing of Therapeutics against SIV and HIV. Annals of the New York Academy of Sciences. 616(1). 599–604. 2 indexed citations
5.
Rothenberg, Mace L., Gregory A. Johnson, Catherine Laughlin, et al.. (1989). Oligodeoxynucleotides as Anti-Sense Inhibitors of Gene Expression: Therapeutic Implications. JNCI Journal of the National Cancer Institute. 81(20). 1539–1544. 47 indexed citations
6.
Grem, Jean L., Dale Shoemaker, Daniel F. Hoth, et al.. (1987). Arabinosyl-5-azacytosine: A novel nucleoside entering clinical trials. Investigational New Drugs. 5(4). 315–328. 18 indexed citations
7.
Vishnuvajjala, B. Rao & James C. Cradock. (1984). Compatibility of plastic infusion devices with diluted N-methylformamide and N,N-dimethylacetamide. American Journal of Health-System Pharmacy. 41(6). 1160–1163. 2 indexed citations
8.
Flora, Karl P., et al.. (1982). Determination of ellipticine in biological samples by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 231(1). 137–144. 10 indexed citations
9.
Flora, Karl P., James C. Cradock, & James A. Kelley. (1982). The Hydrolysis of Spirohydantoin Mustard. Journal of Pharmaceutical Sciences. 71(11). 1206–1211. 11 indexed citations
10.
Cradock, James C., et al.. (1981). Stability of anthracycline antitumor agents in four infusion fluids. American Journal of Health-System Pharmacy. 38(4). 483–486. 5 indexed citations
11.
Cradock, James C., et al.. (1981). Stability of anthracycline antitumor agents in four infusion fluids.. PubMed. 38(4). 483–6. 25 indexed citations
12.
Poochikian, Guirag & James C. Cradock. (1980). Stability of brompton mixtures: Determination of heroin (diacetylmorphine) and cocaine in presence of their hydrolysis products. Journal of Pharmaceutical Sciences. 69(6). 637–639. 14 indexed citations
13.
Poochikian, Guirag & James C. Cradock. (1979). Simple high-performance liquid chromatographic method for the separation of 3,6-diacetylmorphine hydrochloride (heroin) and hydrolysis products. Journal of Chromatography A. 171. 371–376. 35 indexed citations
14.
Trissel, Lawrence A., et al.. (1979). Investigational Drug Information. Drug Intelligence & Clinical Pharmacy. 13(6). 340–343. 4 indexed citations
15.
Poochikian, Guirag & James C. Cradock. (1979). Enhanced Chartreusin Solubility by Hydroxybenzoate Hydrotropy. Journal of Pharmaceutical Sciences. 68(6). 728–732. 56 indexed citations
16.
Cradock, James C., et al.. (1978). Evaluation of some pharmaceutical aspects of intrathecal methotrexate sodium, cytarabine and hydrocortisone sodium succinate.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 35(4). 402–6. 13 indexed citations
17.
Trissel, Lawrence A., et al.. (1978). Investigational Drug Information. Drug Intelligence & Clinical Pharmacy. 12(7). 404–406. 2 indexed citations
18.
Cradock, James C., et al.. (1977). Intrathecal injections--a review of pharmaceutical factors.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 31(5). 237–47. 8 indexed citations
19.
Cradock, James C., et al.. (1972). Postadmission drug and allergy histories recorded by a pharmacist. American Journal of Health-System Pharmacy. 29(3). 250–252. 5 indexed citations
20.
Cradock, James C., et al.. (1970). DAUNOMYCIN METABOLISM IN RAT TISSUE SLICES. Journal of Pharmacology and Experimental Therapeutics. 175(2). 331–337. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026